Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT

v3.19.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2016 $ 4,342 $ 5,433,552 $ (6,129,731) $ (691,837)
Balance at beginning (in shares) at Dec. 31, 2016 43,414,687      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued to advisory board for services $ 34 55,383 55,417
Shares issued to advisory board for services (in shares) 341,667      
Shares issued in conjunction with note payable $ 150 104,850 105,000
Shares issued in conjunction with note payable (in shares) 1,500,000      
issuance of common stock and warrants with short-term convertible notes $ 83 163,088 163,171
issuance of common stock and warrants with short-term convertible notes (in shares) 833,354      
Stock based compensation - related party 45,391 45,391
Preferred right issued to CEO - related party 270,000 270,000
Preferred right issued to CEO - related party (in shares) 1      
Shares issued for services $ 686 755,198 755,884
Shares issued for services (in shares) 6,861,768      
Shares issued for payment of accounts payable $ 15 14,970 14,985
Shares issued for payment of accounts payable (in shares) 150,000      
Shares issued to employees for compensation $ 18 16,902 16,920
Shares issued to employees for compensation (in shares) 175,200      
Reclassification of warrants to equity 1,422,459 1,422,459
Net loss (4,251,264) (4,251,264)
Balance at end at Dec. 31, 2017 $ 5,328 8,281,793 (10,380,995) (2,093,874)
Balance at end (in shares) at Dec. 31, 2017 1 53,276,676      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued to advisory board for services $ 10 2,380 2,390
Shares issued to advisory board for services (in shares) 100,000      
Redeemable shares issued in conjunction with note payable $ 300 103,260 103,560
Redeemable shares issued in conjunction with note payable (in shares) 3,000,000      
Shares issued in conjunction with note payable $ 60 55,440 55,500
Shares issued in conjunction with note payable (in shares) 600,000      
issuance of common stock and warrants with short-term convertible notes $ 83 65,423 65,506
issuance of common stock and warrants with short-term convertible notes (in shares) 833,332      
Shares issued in conjunction with modification of note payable $ 490 327,432 327,922
Shares issued in conjunction with modification of note payable (in shares) 4,895,650      
Preferred right issued to CEO - related party        
Shares issued for services $ 547 229,974 230,521
Shares issued for services (in shares) 5,468,750      
Shares issued for payment of accounts payable $ 1,300 204,465 205,765
Shares issued for payment of accounts payable (in shares) 13,000,000      
Shares issued to employees for compensation $ 10 7,732 7,742
Shares issued to employees for compensation (in shares) 98,000      
Reclassification of warrants to equity        
Net loss (2,620,274) (2,620,274)
Balance at end at Dec. 31, 2018 $ 8,128 $ 9,277,899 $ (13,001,269) $ (3,715,242)
Balance at end (in shares) at Dec. 31, 2018 1 81,272,408